GlassScriptPhysician profile
Sarah Chaudhry
NPI 1699161042
$869.71
in general payments reported to CMS, 2019-2025
16 companies · $110 in 2025
The $110 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.74 · 2020: $33.64 · 2021: $52.85 · 2022: $131 · 2023: $244 · 2024: $269 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $147.31 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $121.46 | 2019-2024 | |
| Alk-Abello, INC | $106.08 | 2023-2025 | Grastek, Ragwitek, Odactra |
| Glaxosmithkline, LLC. | $67.63 | 2022-2025 | Bexsero, Pediarix, Rotarix |
| Takeda Pharmaceuticals U.S.A., INC. | $66.37 | 2021-2023 | |
| Cranial Technologies, INC | $51.43 | 2021-2025 | Doc Band |
| Ironwood Pharmaceuticals, INC | $51.17 | 2024 | |
| Merck Sharp & Dohme LLC | $44.97 | 2022-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Neos Therapeutics, LP | $37.52 | 2024 | Cotempla Xr-Odt |
| Corium, LLC | $36.19 | 2023 | Azstarys |
| Kaleo, INC. | $35.06 | 2022 | |
| Genentech USA, INC. | $33.64 | 2020 | |
| Collegium Pharmaceutical, INC. | $23.46 | 2025 | Jornay Pm |
| Sobi, INC | $17.77 | 2024 | |
| Tris Pharma INC | $15.79 | 2024 | Dyanavel Xr |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $13.86 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.